In vitro evaluation of the cytotoxic and mutagenic potential of the 5-aminolevulinic acid hexylester-mediated photodynamic therapy

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 561, Issue 1-2, 2004, Pages 91-100

  Zenzen, V ^a   Zankl, H ^a  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

5 Aminolevulinic acid hexylester; Chromosome aberration; Micronucleus; Mitotic index; Nuclear division index; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; ESTER; LEVULINIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; HUMAN; HUMAN CELL; ILLUMINATION; IN VITRO STUDY; LIGHT; MEASUREMENT; MICRONUCLEUS; MITOSIS INDEX; MUTAGENESIS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RADIATION DOSE; RED LIGHT; SPECTRAL KARYOTYPING; TUMOR CELL LINE;

AMINOLEVULINIC ACID; CHROMOSOME ABERRATIONS; HUMANS; LIGHT; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MITOTIC INDEX; MUTAGENICITY TESTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SPECTRAL KARYOTYPING; TUMOR CELLS, CULTURED;

EID: 3042592123     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.03.012     Document Type: Article

References (45)

1. Fan K.F., Hopper C., Speight P.M., Buonaccorsi G., MacRobert A.J., Bown S.G. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer. 78:1996;1374-1383
2. Sieron A., Adamek M., Kawczyk-Krupka A., Mazur S., Ilewicz L. Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J. Oral. Pathol. Med. 32:2003;330-336
3. Grant W.E., Hopper C., MacRobert A.J., Speight P.M., Bown S.G. Photodynamic therapy of oral cancer: photosensitization with systemic aminolevulinic acid. Lancet. 342:1993;147-148
4. Jichlinski P., Forrer M., Mizeret J., Glanzmann T., Braichotte D., Wagnieres G., Zimmer G., Guillou L., Schmidlin F., Graber P., van den Bergh H., Leisinger H.J. Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid. Preliminary results. Lasers Surg. Med. 20:1997;402-408
5. Lange N., Jichlinski P., Zellweger M., Forrer M., Marti A., Guillou L., Kucera P., Wagnieres G., van den Bergh H. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Brit. J. Cancer. 80:1999;185-193
6. Gahlen J., Prosst R.L., Stern J. Photodynamic therapy in the gastrointestinal tract. Possibilities and limits. Chirurg. 73:2002;122-131
7. Baumgartner R., Huber R., Schulz H., Stepp H., Rick K., Gamarra F., Leberig A., Roth C. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J. Photochem. Photobiol. B. 36:1996;169-174
8. Wyss P., Fehr M., van den Bergh H., Haller U. Feasibility of photodynamic endometrial ablation without anesthesia. Int. J. Gynaecol. Obstet. 60:1998;287-288
9. Stummer W., Stocker S., Wagner S., Stepp H., Fritsch C., Goetz C., Goetz A., Kiefmann R., Reulen H. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery. 42:1998;518-525
10. Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B. 14:1992;275-292
11. Wolf P., Rieger E., Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J. Am. Acad. Dermatol. 28:1993;17-21
12. Cairnduff F., Stringer M.R., Hudson E.J., Ash D.V., Brown S.B. Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Brit. J. Cancer. 69:1994;605-608
13. Svanberg K., Andersson T., Killander D., Wang I., Stenram U., Andersson-Engels S., Berg R., Johansson J., Svanberg S. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-aminolevulinic acid sensitization and laser irradiation. Brit. J. Dermatol. 130:1994;743-751
14. Calzavara-Pinton P.G. Repetitive photodynamic therapy with topical δ-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin cancer. J. Photochem. Photobiol. B. 29:1995;53-57
15. Wennberg A.-M., Lindholm L.-E., Alpsten M., Larkö O. Treatment of superficial basal cell carcinomas using topically applied delta-aminolevulinic acid and a filtered xenon lamp. Arch. Dermatol. Res. 288:1996;561-564
16. Ortner M.A. Photodynamic therapy of cholangiocarcinoma cancer. Gastrointest. Endosc. Clin. N. Am. 10:2000;481-486
17. Barr H. Photodynamic therapy for Barrett's oesophagus. Int. Photodynam. 1:1995;6-8
18. Gossner L., Stolte M., Sroka R., Rick K., May A., Hahn E.G., Ell C. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology. 114:1998;448-455
19. Ackroyd R., Brown N.J., Davis M.F., Stephenson T.J., Stoddard C.J., Reed M.W. Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus. Dis. Esophagus. 13:2000;18-22
20. Peng Q., Moan J., Farrants G., Danielsen H.E., Rimington C. Localization of potent PS in human tumor LOX by means of laser scanning microscopy. Cancer Lett. 53:1990;129-139
21. Jori G., Reddi E. The role of lipoproteins in the delivery of tumour-targeting photosensitizers. Int. J. Biochem. 25:1993;1369-1375
22. Krammer B. Vascular effects of photodynamic therapy. Anticancer Res. 21(6B):2001;4271-4277
23. Henderson B.W., Dougherty T.J. How does PDT work? Photochem. Photobiol. 55:1992;145-157
24. Laustriat G. Molecular mechanisms of photosensitization. Biochimie. 68:1986;771-778
25. Dougherty T.J. Photodynamic therapy (PDT) of malignant tumors. Crit. Rev. Oncol. Hematol. 2:1984;83-116
26. Weishaupt K.R., Gomer C.J., Dougherty T.J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 36:1976;2326-2329
27. Kloek J., Akkermans W., Beijersbergen van Henegouwen G.M. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem. Photobiol. 67:1998;150-154
28. Fenech M. The in vitro micronucleus technique. Mutat. Res. 455:2000;81-95
29. Macville M., Veldman T., Padilla-Nash H., Wangsa D., O'Brien P., Schröck E., Ried T. Spectral karyotyping, a 24-colour FISH technique for the identification of chromosomal rearrangements. Histochem. Cell Biol. 108:1997;299-305
30. Schröck E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., Garini Y., Ried T. Multicolor spectral karyotyping of human chromosomes. Science. 273:1996;494-497
31. Ried T., Liyanage M., du Manoir S., Heselmeyer K., Auer G., Macville M., Schröck E. Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping. J. Mol. Med. 75:1997;801-814
32. Applied Spectral Imaging, SkyPaint Human Protocol. Rev. B, 1999.
33. Applied Spectral Imaging, SkyView 1.2 - the karyotyping software of the SpectraCube system (manual).
34. Promchainant C. Cytogenetic effect of bleomycin on human leukocytes in vitro. Mutat. Res. 28:1975;107-112
35. Eastmond D.A., Tucker J.D. Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ. Mol. Mutagen. 13:1989;34-43
36. Halkiotis K., Yova D., Pantelias G. In vitro evaluation of the genotoxic and clastogenic potential of photodynamic therapy. Mutagenesis. 14:1999;193-198
37. Zenzen V., Ali T.M., Kuproth M., Zankl H., Janzowski C., Eisenbrand G. Mutagenic and cytotoxic effectiveness of diisopropyl xanthogen polysulphide in human lymphocyte cultures. Mutat. Res. 535:2003;161-170
38. Fiedler D.M., Eckl P.M., Krammer B. Does delta-aminolevulinic acid induce genotoxic effects? J. Photochem. Photobiol. B. 33:1996;39-44
39. Monteiro H.P., Abdalla D.S., Augusto O., Bechara E.J. Free radical generation during delta-aminolevulinic acid autoxidation: induction by hemoglobin and connections with porphyrinpahies. Arch. Biochem. Biophys. 271:1989;206-216
40. Evans H.H., Horng M.F., Ricanati M., Deahl J.T., Oleinick N.L. Mutagenicity of photodynamic therapy as compared to UVC and ionizing radiation in human and murine lymphoblast cell lines. Photochem. Photobiol. 66:1997;690-696
41. Zenzen V., Zankl H. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo. Cancer Lett. 202:2003;35-42
42. Navone N.M., Polo C.F., Frisardi A.L., Andrade N.E., Balle A. Heme biosynthesis in human breast cancer-mimetic "in vitro" studies and some heme enzymic activity levels. Int. J. Biochem. 22:1990;1407-1411
43. Pass H.I. Photodynamic therapy in oncology: mechanisms and clinical use. J. Nat. Cancer Inst. 85:1993;443-456
44. Hinnen P., de Rooij F.W., van Velthuysen M.L., Edixhoven A., van Hillegersberg R., Tilanus H.W., Wilson J.H., Siersema P.D. Biochemical basis of 5-aminolevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus. Brit. J. Cancer. 78:1998;679-682
45. Krieg R.C., Fickweiler S., Wolfbeis O.S., Knuechel R. Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro. Photochem. Photobiol. 72:2000;226-233